Novavax (NVAX) Other financing activities (2012 - 2016)

Novavax's Other financing activities history runs 5 years deep, the most recent figure standing at $10.0 million for Q3 2016.

• In Q3 2016, Other financing activities changed N/A year-over-year to $10.0 million; the TTM figure through Sep 2017 stood at $10.0 million (down 50.0% YoY), while the FY2016 annual figure was $10.0 million, changed N/A from the prior year.
• Other financing activities was $10.0 million for Q3 2016 at Novavax, roughly flat from $10.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $11.6 million in Q1 2015 to a low of -$755000.0 in Q1 2012.
• Historically, Other financing activities has averaged $3.8 million across 5 years, with a median of $0.0 in 2012.
• The sharpest annual moves came in 2015 and 2016: Other financing activities jumped 1160100.0% in 2015, then decreased 14.09% in 2016.
• A 5-year view of Other financing activities shows it stood at -$1000.0 in 2012, then changed by 0.0% to -$1000.0 in 2013, then soared by 200.0% to $1000.0 in 2014, then soared by 1159900.0% to $11.6 million in 2015, then fell by 14.09% to $10.0 million in 2016.
• The last three Other financing activities figures came in at $10.0 million (Q3 2016), $10.0 million (Q1 2016), and $11.6 million (Q1 2015), per Business Quant data.